FY27 Inflection Point: Presales from Filmistan & Thane Set to Flow
After anchoring FY26 with 17% presales growth and modest revenue uptick, Arkade enters Q1 FY27 as a transition quarter. The board meets Aug 11 to approve unaudited results; the Street will be watching whether Filmistan (₹3,000 Cr GDV luxury towers) and Thane (₹2,000 Cr GDV mixed-use) have begun converting into presales. Management guides for presales pickup in FY27, but cautious analysts flag margin compression — the company's operating profit has grown just 3.7% CAGR over five years while revenue grew 13.4%. A preview.
The Setup
Arkade enters Q1 FY27 at a pivotal juncture. FY26 delivered 19% revenue growth to ₹828 Cr and 17% presales growth to ₹901 Cr — solid, but margins remain under pressure. Management has guided for FY27 as an inflection year, anchored on two marquee launches: Filmistan (₹3,000 Cr GDV ultra-luxury 4-acre towers in Goregaon West, 2 x 50-storey buildings) and Thane (₹2,000 Cr GDV mixed-use, valued at ₹172.48 Cr including stamp duty). The real question for Q1: have these projects begun to move? The board meets tomorrow (Aug 11) to approve unaudited results; Street will scrutinize presales trajectory and whether management's FY27 guidance holds.
~₹200–250 Cr
Management guides FY27 as inflection year; Q1 likely reflects early Filmistan & Thane momentum. FY26 quarterly presales averaged ~₹225 Cr.
~₹190–220 Cr
Transition quarter — FY26 Q4 contributed ₹243 Cr. Q1 FY27 reflects cash realization from prior launches (Santacruz Sapphire, ongoing projects) plus early Filmistan/Thane presales-to-cash conversion.
~22–26%
FY26 showed margin headwinds (operating profit growth 3.7% CAGR vs revenue 13.4% CAGR). Street is watching whether Filmistan luxury positioning lifts margins or if scale challenges persist.
₹140–210 range
Stock at ₹134.54 as of Aug 10 — trades below consensus. Limited institutional coverage; MarketsMOJO rates Sell, citing modest long-term growth and technical headwinds.
What Strong vs Weak Looks Like
Strong Q1: Presales ≥₹240 Cr with visible Filmistan/Thane traction (both launches confirmed at investor meetings or disclosures); revenue ≥₹215 Cr; EBITDA margin ≥25% (suggesting operational leverage kicking in). Evidence that luxury positioning is resonating and that large-project execution is on track. Guidance for full-year presales >₹1,000 Cr would be a major signal. Weak Q1: Presales <₹180 Cr (suggesting Filmistan/Thane slower to convert, or competitive headwinds in residential); revenue <₹185 Cr (cash realization miss); EBITDA margin <22% (margin compression deepens). Any commentary on project delays, cost overruns, or missed launches would trigger concern. Cautious FY27 guidance or presales guide cut would be read as inflection delayed.
On Track?
Management has positioned FY27 as a turning point — presales and revenue growth set to reaccelerate as Filmistan (luxury anchor) and Thane (volume play) ramp. Prior trajectory supports this: FY25–FY26 presales growth was 17%, and management's capex on these acquisitions (₹183 Cr for Filmistan, ₹172.48 Cr for Thane land) signals serious commitment. However, the real proof is in Q1 presales. If Filmistan/Thane presales run >₹60 Cr combined in Q1, Street will gain confidence in the FY27 thesis. If they are negligible or delayed, the narrative inverts: Arkade remains a modest-growth residential developer with margin headwinds, not an inflection story.
What the Street Says
Since Last Quarter
Arkade filed several material updates in the 6 weeks since FY26 close (May 27, 2026). On May 29, it announced acquisition of ₹1,100 Cr Kandivali East redevelopment rights (9 societies cluster, ~1.02 Ac). This adds to the Filmistan/Thane pipeline and diversifies Arkade's future revenue mix. On Jul 10, Arkade received a ₹13.74 L GST demand order (Thane Commissionerate) — a procedural tax matter, flagged for disclosure but routine for the sector. More concerning: on Jul 28, the company disclosed an FIR against its former Chief Sales Officer (Mrs. Amita Singh) for alleged ₹2 Cr fraud/customer fund diversion. Arkade said the matter is with authorities; no quantified P&L impact disclosed yet. On Jul 30, Arkade launched Arkade Sapphire in Santacruz West (boutique residential + commercial) — positive new-supply signal. Ownership is stable: promoter 71.19% (unchanged), FII 0.13%, DII 0.08% (minimal institutional interest).
1 · Filmistan & Thane Presales
Are either project showing >₹30–40 Cr presales in Q1? Any project launch updates or customer pipeline commentary? If both remain silent or low, the inflection thesis is at risk.
2 · Margin Trajectory
Does EBITDA margin hold ≥24% in Q1, or does it slip further? Any quantified impact from GST penalty or CSO fraud on costs/receivables? Margin recovery is the Street's #1 skepticism — watch closely.
3 · FY27 Guidance & Presales Outlook
Management's full-year FY27 presales guidance is crucial. A target >₹1,000 Cr (vs ₹901 Cr in FY26) confirms Filmistan/Thane ramp. A guidance miss or cut would signal execution risk or competitive headwinds. Also: any commentary on Kandivali redevelopment timelines or land acquisition costs?
Arkade's Q1 FY27 result is a litmus test for management's inflection thesis. The company has assembled a credible pipeline — ₹5,000 Cr GDV in Filmistan & Thane, plus Kandivali redevelopment — but the proof is presales traction and margin recovery. Street is skeptical (thin coverage, Sell-rated, technical headwinds), and the stock trades below consensus target. If Q1 shows Filmistan/Thane momentum and EBITDA margin stabilization, narrative resets toward 2026–2027 re-rating. If presales remain modest and margins compress further, Arkade remains a modest-growth story with execution risk. Board approves results on Aug 11; report date TBD but likely within days.
Informational and educational content only. Not investment advice.